Literature DB >> 15237194

Establishment and characterization of a human gastric carcinoma cell line TMC-1.

Rong-Yaun Shyu1, Shun-Yuan Jiang, Yiin-Jeng Jong, Kuo-Chen Cheng, Chi-Hung Lin, Jyh-Cherng Yu, Ming-Fang Wu, Tzu-Ming Chang.   

Abstract

Established cancer cell lines are useful in the study of various cancers. We established a human gastric carcinoma cell line TMC-1 derived from the lymph node of a moderately differentiated adenocarcinoma of the stomach. TMC-1 cells grew in vitro as a mixture of attached and suspension cells, and exhibited spindle or ovoid morphology. They had a population doubling time of 15 h, a plating efficiency of 61%, formed colonies in semisolid agar, secreted the tumor marker CA 19-9, and were tumorigenic in athymic nude mice. The cells expressed E-cadherin and beta-catenin. The karyotypic analysis demonstrated hyperdiploid features with a modal chromosome of 53. The cell had the deletion at chromosome 18q and gains at chromosome 2p13-25, 5p15, 5q21-35, 7, 8q24, 9q, 11, 12p, 14q24-32 and 20. Analysis by fluorescence in situ hybridization showed the deletion at 7qtel and duplication at 7q11.2 at the rearranged chromosome 7. Growth of TMC-1 cells was inhibited by 27-32% by interferon-alpha (2,000 U/ml) and by interferon-gamma with an IC50 of 125 U/ml. The cell line is tumorigenic in vivo, and its growth is moderately inhibited by interferon-alpha and interferon-gamma. It can be used to develop new modalities of human gastric cancer treatment. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15237194     DOI: 10.1159/000078426

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  2 in total

Review 1.  Update on a tumor-associated NADH oxidase in gastric cancer cell growth.

Authors:  Hsiao-Ling Cheng; Yi-Hui Lee; Tein-Ming Yuan; Shi-Wen Chen; Pin-Ju Chueh
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

2.  CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.

Authors:  Jeffrey A Norton; Christine M Ham; Jacques Van Dam; R Brooke Jeffrey; Teri A Longacre; David G Huntsman; Nicki Chun; Allison W Kurian; James M Ford
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.